Introduction: Research is a purpose-directed activity. Although aims, goals, objectives, and targets are interrelated statements of purpose, they differ in hierarchy, scope, measurability, timeframe, and significance. This brief review clarifies these terms and describes the characteristics of a good research objective. Methods: Relevant papers were analyzed to delineate the definitions, interrelations, and distinctions among aims, goals, objectives, and targets in research projects. Results: The apparent purpose of a study (objectives and goals) addresses specific research questions, whereas its deeper purpose (aim) represents the underlying reason for conducting the study. Aims express ideals and long-term direction; goals outline the primary intent and problem to be addressed; objectives link intention to action by specifying how the research question will be answered; and targets indicate desired values of outcome indicators. A strong objective should be SMART (specific, measurable, achievable, relevant, and time-bound). Conclusion: Clear articulation of research purpose facilitates translation of findings into practice and enhances the overall quality of research.
Naltrexone, a long-acting opioid receptor antagonist, is commonly utilized to avert relapse in individuals with opioid or alcohol dependence. While its efficacy in modifying cue-reactivity and lowering desire is well documented, less is known regarding its ability to elicit negative sensory-emotional reactions, particularly in response to olfactory stimulation. We present a rare case of a 16-year-old male with a history of cannabis usage who experienced acute episodes of respiratory distress after starting oral naltrexone (50 mg/day). These episodes were consistently triggered by the smell of opium or cannabis smoke, despite the patient’s abstinence. The reactions were severe enough to necessitate multiple emergency medical procedures. The patient had a prior adverse reaction to morphine and a history of multiple drug allergies, suggesting a possible underlying sensitivity to opioid system modulation. The symptoms resolved after discontinuation of naltrexone. This case raises significant clinical and neurobiological concerns about the role of opioid antagonism in modifying olfactory and emotional processing. We propose that naltrexoneinduced disinhibition in olfactory-limbic circuits may have contributed to heightened sensory gain and conditioned unpleasant reactions in a sensitized individual. More research is needed to understand the mechanisms driving this unusual yet important reaction.
Electroconvulsive therapy (ECT) is a well-established intervention for treatment-resistant major depressive disorder (MDD). Although the neurobiological ramifications of ECT, particularly in relation to the mesolimbic dopaminergic system, have been correlated with the modulation of reward and reinforcement pathways, the capacity of ECT to influence substance-related behaviors remains inadequately elucidated. We report the case of a 42-year-old Iranian woman with a 14-year history of treatment-resistant MDD and no prior history of tobacco or other substance use. Following a second session of inpatient ECT, the patient experienced a sudden and intense craving for cigarettes, leading to the immediate initiation of daily smoking. This pattern of tobacco use persisted for several years, despite multiple motivated attempts at cessation. The patient’s psychiatric management included standard pharmacotherapy and supportive interventions, but ongoing nicotine dependence remained challenging. There was no personal or family history of substance use, and no exposure to smoking in the inpatient setting, aside from a shared room with a smoker in a different ward. To our knowledge, this is the first documented case of cigarette smoking initiation following ECT in a non-smoking patient with MDD. The case underscores the need for heightened clinical vigilance and further investigation into ECT’s effects on addictive vulnerability and reward processing.
